aidsmap's Avatar

aidsmap

@aidsmap.bsky.social

aidsmap became part of HIV charity Terrence Higgins Trust in 2025. Under Terrence Higgins Trust’s stewardship, the work of aidsmap continues to build on NAM’s legacy and serve the diverse needs of the HIV community.

145 Followers  |  1 Following  |  96 Posts  |  Joined: 06.03.2025  |  1.7782

Latest posts by aidsmap.bsky.social on Bluesky

Preview
Eight ways to look after your health Easy-to-read and illustrated information on healthy living for people with HIV.

There’s a lot you can do to take care of your health. Exercise, a balanced diet, sleep, giving up smoking and cutting back on alcohol are all important. HIV treatment will strengthen your immune system and prevent illnesses.

05.08.2025 11:02 — 👍 1    🔁 1    💬 0    📌 0
Preview
What are HIV stigma and discrimination? People living with HIV often feel nervous about telling others that they have HIV due to the fear of stigma or discrimination.

People living with HIV often feel nervous about telling others that they have HIV due to the fear of stigma or discrimination. While stigma may be found in people’s attitudes or beliefs, discrimination is about actual behaviour

04.08.2025 11:02 — 👍 1    🔁 0    💬 0    📌 0
Post image

aidsmap was an official scientific media partner for the 13th @iasociety.bsky.social Conference on HIV Science #IAS2025, held in Rwanda earlier this month.
Catch up with all our news stories and summary bulletins on aidsmap.com
www.aidsmap.com/conferences/...

31.07.2025 13:13 — 👍 2    🔁 2    💬 0    📌 0
Preview
Integration of HIV services – what does that really mean? At the 13th International AIDS Society Conference on HIV Science (IAS 2025) in Kigali, Rwanda, integration with the wider healthcare system was widely presented as a practical response to declini...

News from #IAS2025: Integration of HIV services – what does that really mean? @iasociety.bsky.social
www.aidsmap.com/news/jul-2025/integration-hiv-services-what-does-really-mean

31.07.2025 12:52 — 👍 0    🔁 1    💬 0    📌 0
Preview
A healthy weight Easy-to-read and illustrated information on diet and exercise for people living with HIV.

Have you seen our easy-to-read and illustrated information on diet and exercise for people living with HIV? You can now also download it as a PDF leaflet.

31.07.2025 12:02 — 👍 0    🔁 1    💬 0    📌 0
Preview
Lenacapavir PrEP ‘special cases’: young people, missed doses and drug interactions An entire session at the 13th International AIDS Society Conference on HIV Science (IAS 2025) in Kigali, Rwanda was devoted to the PURPOSE 1 and PURPOSE 2 studies of the six-monthly injectable PrEP dr...

News from #IAS2025: Lenacapavir PrEP ‘special cases’: young people, missed doses and drug interactions
www.aidsmap.com/news/jul-202... @iasociety.bsky.social

30.07.2025 15:58 — 👍 0    🔁 1    💬 0    📌 0
Preview
HIV treatment breaks Taking a planned break from your HIV treatment is sometimes called a 'drug holiday' - they're not recommended in current HIV treatment guidelines.

Taking a planned break from your HIV treatment is sometimes called a ‘structured treatment interruption'. There has been a lot of research into treatment breaks, and this has shown that there are more risks than benefits.

30.07.2025 12:32 — 👍 0    🔁 0    💬 0    📌 0
Preview
The funding scramble: countries desperately seek HIV finance solutions How will countries fund and sustain their national HIV responses moving forward? This was a central question at the recent 13th International AIDS Society Conference on HIV Science (IAS 2025) in ...

News from #IAS2025: The funding scramble: countries desperately seek HIV finance solutions @iasociety.bsky.social
www.aidsmap.com/news/jul-202...

30.07.2025 11:20 — 👍 1    🔁 2    💬 0    📌 1
Preview
The stages of HIV infection If treatment is not taken, seroconversion is followed by asymptomatic HIV, symptomatic HIV and AIDS.

What are the stages of HIV infection?
If treatment is not taken, seroconversion is followed by asymptomatic HIV, symptomatic HIV and AIDS. However, effective HIV treatment profoundly changes the course of infection.

29.07.2025 11:02 — 👍 1    🔁 0    💬 0    📌 0
Preview
What are the side effects of <i>Truvada</i> used for PrEP? Truvada is a combination pill that contains emtricitabine and tenofovir disoproxil fumarate. It is used as pre-exposure prophylaxis (PrEP) to prevent HIV

Truvada is a combination pill that contains emtricitabine & tenofovir disoproxil. It's used as PrEP to prevent HIV infection. It's generally safe, but like all medication, can have side effects in some people.

28.07.2025 11:03 — 👍 2    🔁 1    💬 0    📌 0
Preview
Non-Hodgkin lymphoma and HIV Non-Hodgkin lymphoma is one of the two most common cancers in people living with HIV in the UK.

Non-Hodgkin lymphoma (NHL) is one of the two most common cancers in people living with HIV in the UK. The damage HIV does to the immune system makes people living with HIV more vulnerable to NHL than other people.

25.07.2025 13:04 — 👍 1    🔁 1    💬 0    📌 0
Post image

Our final news summary from #IAS2025 is out now incl:
-Does 6-monthly PrEP have a future after funding collapse?
-HIV integration sparks fierce debate
-US funding cuts & HIV testing/treatment
-Antibodies shows promise in the search for a cure
www.aidsmap.com/bulletin/con... @iasociety.bsky.social

23.07.2025 15:23 — 👍 4    🔁 4    💬 0    📌 0
Preview
Is HIV integration a response or a death sentence? Communities demand answers "When our leaders talk about integration, what do they really mean? It's hypocrisy when they tell us to use outpatient [clinics], when they know mobile clinics exist because of their criminalisation o...

News from #IAS2025: Is HIV integration a response or a death sentence? Communities demand answers @iasociety.bsky.social
www.aidsmap.com/news/jul-202...

23.07.2025 14:16 — 👍 1    🔁 2    💬 0    📌 0
Preview
Does six-monthly PrEP have a future following the collapse of global HIV funding? “Lenacapavir is a product with real transformational potential that has the power to change the history of HIV,” Carolyn Amole of the Clinton Health Access Initiative (CHAI) told last week’s 13th Inte...

News from #IAS2025: Does six-monthly PrEP have a future following the collapse of global HIV funding?
www.aidsmap.com/news/jul-202...
@iasociety.bsky.social

23.07.2025 13:51 — 👍 1    🔁 0    💬 0    📌 0
Preview
Stepping into the AI-driven future of HIV prevention and care Artifical intelligence (AI) featured prominently at the 13th International AIDS Society Conference on HIV Science (IAS 2025) in Kigali, Rwanda last week. Experts expressed excitement – and some cautio...

News from #IAS2025: Stepping into the AI-driven future of HIV prevention and care @iasociety.bsky.social
aidsmap.com/news/jul-202...

23.07.2025 08:49 — 👍 0    🔁 1    💬 0    📌 1
Preview
Children born with HIV have persistent inflammation markers linked to heart disease Two studies of children with HIV presented at the 13th International AIDS Society Conference on HIV Science (IAS 2025) in Kigali, Rwanda showed that even if they are on antiretroviral therapy (ART) an...

News from #IAS2025: Children born with HIV have persistent inflammation markers linked to heart disease
www.aidsmap.com/news/jul-202...
@iasociety.bsky.social

23.07.2025 08:30 — 👍 3    🔁 2    💬 0    📌 0
Preview
Smoking and HIV Smoking is one of the most important causes of illness and death in HIV-positive people. HIV-positive smokers have a greater risk of lung cancer

Smoking is one of the most important causes of illness and death in HIV-positive people. For people with HIV who are undetectable, smoking has a much greater impact on life expectancy than HIV.

22.07.2025 13:02 — 👍 0    🔁 0    💬 0    📌 0
Preview
The US cuts challenge African funders and governments to provide new models of PrEP access A high-level panel discussion convened at the 13th International AIDS Society Conference on HIV Science (IAS 2025) in Kigali, Rwanda drew together representatives from global funding foundations, nati...

News from #IAS2025: The US cuts challenge African funders and governments to provide new models of PrEP access
www.aidsmap.com/news/jul-202... @iasociety.bsky.social

22.07.2025 13:01 — 👍 2    🔁 2    💬 0    📌 0
Preview
Conflicts and humanitarian crises create new HIV vulnerabilities Garnering a standing ovation at IAS 2025, Sameer Sah, from Medical Aid for Palestinians, provided a devastating first-hand account of what’s been happening for nearly two years in Gazan healthcare set...

News from #IAS2025: Conflicts and humanitarian crises create new HIV vulnerabilities
www.aidsmap.com/news/jul-202... @iasociety.bsky.social

21.07.2025 15:34 — 👍 1    🔁 1    💬 0    📌 0
Preview
US funding cuts cause immediate drops in numbers testing and on HIV treatment Cuts in US funding for HIV programmes have already led to declines in testing and treatment starts in several countries, research presented last week at the&nbsp;13th International AIDS Society Confer...

News from #IAS2025: US funding cuts cause immediate drops in numbers testing and on HIV treatment @iasociety.bsky.social www.aidsmap.com/news/jul-202...

21.07.2025 13:53 — 👍 1    🔁 5    💬 0    📌 0
Preview
How treatment works Easy-to-read and illustrated information on how different types of anti-HIV drugs work against HIV.

All anti-HIV drugs try to prevent HIV infecting new cells, but different types of drugs do it in different ways. 
Find out how treatment works on our illustrated page, or download it as a PDF leaflet

21.07.2025 11:46 — 👍 1    🔁 0    💬 0    📌 0
Preview
Broadly neutralising antibodies plus immune modulator may delay HIV rebound More than half of people who received a pair of broadly neutralising antibodies (bnAbs) plus the immune-modulating drug N-803 (Anktiva) had delayed viral rebound or maintained a low or suppressed vira...

News from #IAS2025: Broadly neutralising antibodies plus immune modulator may delay HIV rebound @iasociety.bsky.social
www.aidsmap.com/news/jul-202...

21.07.2025 11:36 — 👍 1    🔁 1    💬 0    📌 0

Delighted to see our long-acting injectible ART trial (IMPALA) presented at #IAS2025. 2-monthly injections are non-inferior to daily pill taking and overwhelmingly preferred. Next challenge is expanding access to LA ART; excellent news the WHO has recommended LA CAB+RPV in treatment guidelines.

18.07.2025 15:03 — 👍 2    🔁 1    💬 1    📌 0
Post image

Our 2nd #IAS2025 news summary is out now, incl:
-Monthly oral PrEP pill
-Injectable ART works for people with adherence challenges
-ART switches don't reduce weight
-PEPFAR cuts & PrEP
www.aidsmap.com/bulletin/con...
@iasociety.bsky.social

18.07.2025 12:32 — 👍 3    🔁 1    💬 0    📌 0
Preview
Injectable HIV treatment works for people with poor HIV control in Africa Injectable treatment with long-acting cabotegravir and rilpivirine is as effective as dolutegravir-based oral treatment in adults with HIV in sub-Saharan Africa who have a history of treatment non-adh...

News from #IAS2025: Injectable HIV treatment works for people with poor HIV control in Africa
www.aidsmap.com/news/jul-2025/injectable-hiv-treatment-works-people-poor-hiv-control-africa
@iasociety.bsky.social

18.07.2025 12:19 — 👍 1    🔁 2    💬 0    📌 1
Preview
Lenacapavir and cabotegravir PrEP supported for use in pregnancy and breastfeeding New data presented at the 13th International AIDS Society Conference on HIV Science (IAS 2025) yesterday show that two long-acting injectable PrEP options, lenacapavir and cabotegravir, are safe, well...

News from #IAS2025: Lenacapavir and cabotegravir PrEP supported for use in pregnancy and breastfeeding @iasociety.bsky.social
www.aidsmap.com/news/jul-202...

18.07.2025 11:55 — 👍 6    🔁 6    💬 0    📌 0
Preview
Intermittent HIV treatment dosing may be a response to the funding crisis, but adolescent study raises concerns Intermittent HIV treatment schedules – such as weekends off treatment – may not be inferior to continuous treatment in adults with well-controlled HIV, but they are not suitable for adolescents with H...

News from #IAS2025: Intermittent HIV treatment dosing may be a response to the funding crisis, but adolescent study raises concerns @iasociety.bsky.social
www.aidsmap.com/news/jul-202...

17.07.2025 15:47 — 👍 0    🔁 1    💬 0    📌 0
Preview
Scaling back PEPFAR will leave 700,000 without PrEP and cause 6700 new HIV infections within a year The 13th International AIDS Society Conference on HIV Science (IAS 2025)&nbsp;in Kigali, Rwanda has been dominated by the impact of the US government funding cuts. Especially urgent are discussions on...

News from #IAS2025: Scaling back PEPFAR will leave 700,000 without PrEP and cause 6700 new HIV infections within a year @iasociety.bsky.social
aidsmap.com/news/jul-202...

17.07.2025 14:48 — 👍 3    🔁 6    💬 0    📌 0
Post image

Want to keep up to date with the latest HIV news?
Subscribe to aidsmap bulletins and we'll share HIV research and developments from around the world and news from international HIV conferences.
https://www.aidsmap.com/subscribe

17.07.2025 11:02 — 👍 3    🔁 2    💬 0    📌 0
Preview
Treatment changes do not reduce weight in people with HIV A randomised trial presented on Tuesday at the&nbsp;13th&nbsp;International AIDS Society Conference on HIV Science (IAS 2025) showed that switching from medications thought to cause weight gain did no...

News from #IAS2025: Treatment changes do not reduce weight in people with HIV
www.aidsmap.com/news/jul-2025/treatment-changes-do-not-reduce-weight-people-hiv
@iasociety.bsky.social

17.07.2025 10:01 — 👍 1    🔁 1    💬 0    📌 0

@aidsmap is following 1 prominent accounts